{"entity":{"type":"insider","cik":"0001383292","url":"/insider/0001383292","json_url":"/insider/0001383292.json","name":"Rowland Charles A Jr","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":30,"n_filings":19,"first":"2008-11-05","last":"2025-10-28","span_basis":"filed_date"},"name_variants":[{"name":"Rowland Charles A Jr","source":"filing","n_filings":19,"first_seen":"2008-11-05","last_seen":"2025-10-28"}],"transactions":[{"id":4298289,"accession":"0001193125-25-254300","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193125-25-254300","line_url":"/filing/0001193125-25-254300#line-4","is_derivative":false,"issuer_cik":"0001383292","issuer_name":"Viking Therapeutics, Inc.","issuer_ticker":"VKTX","issuer_name_source":null,"issuer_url":"/issuer/0001383292","owner_cik":"0001383292","owner_name":"Rowland Charles A Jr","owner_display_name":"Rowland Charles A Jr","owner_url":"/insider/0001383292","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.00001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60000.0,"shares_display":"60,000","price_per_share":35.5713,"price_display":"35.57","price_state":"stated","total_value":2134278.0,"total_display":"2,134,278.00","total_whole":"2,134,278","shares_owned_after":30000.0,"shares_owned_after_display":"30,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-27","filed_date":"2025-10-28","scope":"insider"},{"id":8711039,"accession":"0001415889-23-015864","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-23-015864","line_url":"/filing/0001415889-23-015864#line-2","is_derivative":false,"issuer_cik":"0001383292","issuer_name":"Generation Bio Co.","issuer_ticker":"GBIO","issuer_name_source":null,"issuer_url":"/issuer/0001383292","owner_cik":"0001383292","owner_name":"Rowland Charles A Jr","owner_display_name":"Rowland Charles A Jr","owner_url":"/insider/0001383292","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":150000.0,"shares_display":"150,000","price_per_share":1.5,"price_display":"1.50","price_state":"stated","total_value":225000.0,"total_display":"225,000.00","total_whole":"225,000","shares_owned_after":534757.0,"shares_owned_after_display":"534,757","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-04","filed_date":"2023-12-05","scope":"insider"},{"id":8711037,"accession":"0001415889-23-015864","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-23-015864","line_url":"/filing/0001415889-23-015864#line-1","is_derivative":false,"issuer_cik":"0001383292","issuer_name":"Generation Bio Co.","issuer_ticker":"GBIO","issuer_name_source":null,"issuer_url":"/issuer/0001383292","owner_cik":"0001383292","owner_name":"Rowland Charles A Jr","owner_display_name":"Rowland Charles A Jr","owner_url":"/insider/0001383292","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":192960.0,"shares_display":"192,960","price_per_share":1.31,"price_display":"1.31","price_state":"stated","total_value":252777.6,"total_display":"252,777.60","total_whole":"252,778","shares_owned_after":384757.0,"shares_owned_after_display":"384,757","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-01","filed_date":"2023-12-05","scope":"insider"},{"id":8723694,"accession":"0001209191-23-030796","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-030796","line_url":"/filing/0001209191-23-030796#line-2","is_derivative":false,"issuer_cik":"0001383292","issuer_name":"Viking Therapeutics, Inc.","issuer_ticker":"VKTX","issuer_name_source":null,"issuer_url":"/issuer/0001383292","owner_cik":"0001383292","owner_name":"Rowland Charles A Jr","owner_display_name":"Rowland Charles A Jr","owner_url":"/insider/0001383292","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.00001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":25.0,"price_display":"25.00","price_state":"stated","total_value":1000000.0,"total_display":"1,000,000.00","total_whole":"1,000,000","shares_owned_after":30000.0,"shares_owned_after_display":"30,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-16","filed_date":"2023-05-18","scope":"insider"},{"id":6129958,"accession":"0001415889-22-009796","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-22-009796","line_url":"/filing/0001415889-22-009796#line-1","is_derivative":false,"issuer_cik":"0001383292","issuer_name":"Generation Bio Co.","issuer_ticker":"GBIO","issuer_name_source":null,"issuer_url":"/issuer/0001383292","owner_cik":"0001383292","owner_name":"Rowland Charles A Jr","owner_display_name":"Rowland Charles A Jr","owner_url":"/insider/0001383292","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15750.0,"shares_display":"15,750","price_per_share":5.26,"price_display":"5.26","price_state":"stated","total_value":82845.0,"total_display":"82,845.00","total_whole":"82,845","shares_owned_after":191797.0,"shares_owned_after_display":"191,797","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-19","filed_date":"2022-09-20","scope":"insider"},{"id":6528672,"accession":"0001415889-22-009776","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-22-009776","line_url":"/filing/0001415889-22-009776#line-2","is_derivative":false,"issuer_cik":"0001383292","issuer_name":"Generation Bio Co.","issuer_ticker":"GBIO","issuer_name_source":null,"issuer_url":"/issuer/0001383292","owner_cik":"0001383292","owner_name":"Rowland Charles A Jr","owner_display_name":"Rowland Charles A Jr","owner_url":"/insider/0001383292","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":33481.0,"shares_display":"33,481","price_per_share":5.48,"price_display":"5.48","price_state":"stated","total_value":183475.88,"total_display":"183,475.88","total_whole":"183,476","shares_owned_after":176047.0,"shares_owned_after_display":"176,047","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-16","filed_date":"2022-09-19","scope":"insider"},{"id":6528668,"accession":"0001415889-22-009776","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-22-009776","line_url":"/filing/0001415889-22-009776#line-1","is_derivative":false,"issuer_cik":"0001383292","issuer_name":"Generation Bio Co.","issuer_ticker":"GBIO","issuer_name_source":null,"issuer_url":"/issuer/0001383292","owner_cik":"0001383292","owner_name":"Rowland Charles A Jr","owner_display_name":"Rowland Charles A Jr","owner_url":"/insider/0001383292","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":17147.0,"shares_display":"17,147","price_per_share":5.41,"price_display":"5.41","price_state":"stated","total_value":92765.27,"total_display":"92,765.27","total_whole":"92,765","shares_owned_after":142566.0,"shares_owned_after_display":"142,566","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-15","filed_date":"2022-09-19","scope":"insider"},{"id":6528659,"accession":"0001415889-22-009671","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-22-009671","line_url":"/filing/0001415889-22-009671#line-2","is_derivative":false,"issuer_cik":"0001383292","issuer_name":"Generation Bio Co.","issuer_ticker":"GBIO","issuer_name_source":null,"issuer_url":"/issuer/0001383292","owner_cik":"0001383292","owner_name":"Rowland Charles A Jr","owner_display_name":"Rowland Charles A Jr","owner_url":"/insider/0001383292","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5600.0,"shares_display":"5,600","price_per_share":5.295,"price_display":"5.30","price_state":"stated","total_value":29652.0,"total_display":"29,652.00","total_whole":"29,652","shares_owned_after":125419.0,"shares_owned_after_display":"125,419","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-14","filed_date":"2022-09-15","scope":"insider"},{"id":6528654,"accession":"0001415889-22-009671","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-22-009671","line_url":"/filing/0001415889-22-009671#line-1","is_derivative":false,"issuer_cik":"0001383292","issuer_name":"Generation Bio Co.","issuer_ticker":"GBIO","issuer_name_source":null,"issuer_url":"/issuer/0001383292","owner_cik":"0001383292","owner_name":"Rowland Charles A Jr","owner_display_name":"Rowland Charles A Jr","owner_url":"/insider/0001383292","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":18784.0,"shares_display":"18,784","price_per_share":5.204,"price_display":"5.20","price_state":"stated","total_value":97751.936,"total_display":"97,751.94","total_whole":"97,752","shares_owned_after":119819.0,"shares_owned_after_display":"119,819","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-13","filed_date":"2022-09-15","scope":"insider"},{"id":6770780,"accession":"0001104659-22-085790","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-085790","line_url":"/filing/0001104659-22-085790#line-1","is_derivative":false,"issuer_cik":"0001383292","issuer_name":"Nabriva Therapeutics plc","issuer_ticker":"NBRV","issuer_name_source":null,"issuer_url":"/issuer/0001383292","owner_cik":"0001383292","owner_name":"Rowland Charles A Jr","owner_display_name":"Rowland Charles A Jr","owner_url":"/insider/0001383292","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8496.0,"shares_display":"8,496","price_per_share":0.175,"price_display":"0.18","price_state":"stated","total_value":1486.8,"total_display":"1,486.80","total_whole":"1,487","shares_owned_after":15277.0,"shares_owned_after_display":"15,277","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-01","filed_date":"2022-08-03","scope":"insider"},{"id":5248050,"accession":"0001104659-21-100288","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-100288","line_url":"/filing/0001104659-21-100288#line-1","is_derivative":false,"issuer_cik":"0001383292","issuer_name":"Nabriva Therapeutics plc","issuer_ticker":"NBRV","issuer_name_source":null,"issuer_url":"/issuer/0001383292","owner_cik":"0001383292","owner_name":"Rowland Charles A Jr","owner_display_name":"Rowland Charles A Jr","owner_url":"/insider/0001383292","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":777.0,"shares_display":"777","price_per_share":1.2,"price_display":"1.20","price_state":"stated","total_value":932.4,"total_display":"932.40","total_whole":"932","shares_owned_after":23773.0,"shares_owned_after_display":"23,773","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-02","filed_date":"2021-08-04","scope":"insider"},{"id":4397819,"accession":"0001415889-21-000310","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-21-000310","line_url":"/filing/0001415889-21-000310#line-1","is_derivative":false,"issuer_cik":"0001383292","issuer_name":"Generation Bio Co.","issuer_ticker":"GBIO","issuer_name_source":null,"issuer_url":"/issuer/0001383292","owner_cik":"0001383292","owner_name":"Rowland Charles A Jr","owner_display_name":"Rowland Charles A Jr","owner_url":"/insider/0001383292","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20408.0,"shares_display":"20,408","price_per_share":24.5,"price_display":"24.50","price_state":"stated","total_value":499996.0,"total_display":"499,996.00","total_whole":"499,996","shares_owned_after":101035.0,"shares_owned_after_display":"101,035","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-11","filed_date":"2021-01-13","scope":"insider"},{"id":2266062,"accession":"0001179110-20-012096","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-20-012096","line_url":"/filing/0001179110-20-012096#line-2","is_derivative":false,"issuer_cik":"0001383292","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001383292","owner_cik":"0001383292","owner_name":"Rowland Charles A Jr","owner_display_name":"Rowland Charles A Jr","owner_url":"/insider/0001383292","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10909.0,"shares_display":"10,909","price_per_share":117.82,"price_display":"117.82","price_state":"stated","total_value":1285298.38,"total_display":"1,285,298.38","total_whole":"1,285,298","shares_owned_after":3562.0,"shares_owned_after_display":"3,562","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-17","filed_date":"2020-12-18","scope":"insider"},{"id":2265871,"accession":"0001179110-20-010821","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001179110-20-010821","line_url":"/filing/0001179110-20-010821","is_derivative":false,"issuer_cik":"0001383292","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001383292","owner_cik":"0001383292","owner_name":"Rowland Charles A Jr","owner_display_name":"Rowland Charles A Jr","owner_url":"/insider/0001383292","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5522.0,"shares_display":"5,522","price_per_share":98.7316153567548,"price_display":"98.73","price_state":"stated","total_value":545195.98,"total_display":"545,195.98","total_whole":"545,196","shares_owned_after":4256.0,"shares_owned_after_display":"4,256","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-03","filed_date":"2020-11-04","scope":"insider","n_lines":3},{"id":2265858,"accession":"0001179110-20-010821","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-20-010821","line_url":"/filing/0001179110-20-010821#line-2","is_derivative":false,"issuer_cik":"0001383292","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001383292","owner_cik":"0001383292","owner_name":"Rowland Charles A Jr","owner_display_name":"Rowland Charles A Jr","owner_url":"/insider/0001383292","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4478.0,"shares_display":"4,478","price_per_share":99.11,"price_display":"99.11","price_state":"stated","total_value":443814.58,"total_display":"443,814.58","total_whole":"443,815","shares_owned_after":3562.0,"shares_owned_after_display":"3,562","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-02","filed_date":"2020-11-04","scope":"insider"},{"id":2778323,"accession":"0000899243-20-017105","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-017105","line_url":"/filing/0000899243-20-017105#line-2","is_derivative":false,"issuer_cik":"0001383292","issuer_name":"Generation Bio Co.","issuer_ticker":"GBIO","issuer_name_source":null,"issuer_url":"/issuer/0001383292","owner_cik":"0001383292","owner_name":"Rowland Charles A Jr","owner_display_name":"Rowland Charles A Jr","owner_url":"/insider/0001383292","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30000.0,"shares_display":"30,000","price_per_share":19.0,"price_display":"19.00","price_state":"stated","total_value":570000.0,"total_display":"570,000.00","total_whole":"570,000","shares_owned_after":80627.0,"shares_owned_after_display":"80,627","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-16","filed_date":"2020-06-18","scope":"insider"},{"id":8449360,"accession":"0001179110-19-008066","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179110-19-008066","line_url":"/filing/0001179110-19-008066","is_derivative":false,"issuer_cik":"0001383292","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001383292","owner_cik":"0001383292","owner_name":"Rowland Charles A Jr","owner_display_name":"Rowland Charles A Jr","owner_url":"/insider/0001383292","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11818.0,"shares_display":"11,818","price_per_share":95.14827889659841,"price_display":"95.15","price_state":"stated","total_value":1124462.36,"total_display":"1,124,462.36","total_whole":"1,124,462","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-20","filed_date":"2019-06-24","scope":"insider","n_lines":3},{"id":6541295,"accession":"0001104659-18-074905","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-18-074905","line_url":"/filing/0001104659-18-074905#line-1","is_derivative":false,"issuer_cik":"0001383292","issuer_name":"Nabriva Therapeutics plc","issuer_ticker":"NBRV","issuer_name_source":null,"issuer_url":"/issuer/0001383292","owner_cik":"0001383292","owner_name":"Rowland Charles A Jr","owner_display_name":"Rowland Charles A Jr","owner_url":"/insider/0001383292","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":53000.0,"shares_display":"53,000","price_per_share":1.31,"price_display":"1.31","price_state":"stated","total_value":69430.0,"total_display":"69,430.00","total_whole":"69,430","shares_owned_after":53000.0,"shares_owned_after_display":"53,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-24","filed_date":"2018-12-27","scope":"insider"},{"id":6291675,"accession":"0001209191-18-034490","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-034490","line_url":"/filing/0001209191-18-034490#line-1","is_derivative":false,"issuer_cik":"0001383292","issuer_name":"Viking Therapeutics, Inc.","issuer_ticker":"VKTX","issuer_name_source":null,"issuer_url":"/issuer/0001383292","owner_cik":"0001383292","owner_name":"Rowland Charles A Jr","owner_display_name":"Rowland Charles A Jr","owner_url":"/insider/0001383292","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.00001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30000.0,"shares_display":"30,000","price_per_share":5.16,"price_display":"5.16","price_state":"stated","total_value":154800.0,"total_display":"154,800.00","total_whole":"154,800","shares_owned_after":30000.0,"shares_owned_after_display":"30,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-29","filed_date":"2018-05-31","scope":"insider"},{"id":3366037,"accession":"0001127602-12-009534","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001127602-12-009534","line_url":"/filing/0001127602-12-009534","is_derivative":false,"issuer_cik":"0000946840","issuer_name":"VIROPHARMA INC","issuer_ticker":"VPHM","issuer_name_source":null,"issuer_url":"/issuer/0000946840","owner_cik":"0001383292","owner_name":"Rowland Charles A Jr","owner_display_name":"Rowland Charles A Jr","owner_url":"/insider/0001383292","role":"Officer (VP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (VP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":82750.0,"shares_display":"82,750","price_per_share":32.116391238670694,"price_display":"32.12","price_state":"stated","total_value":2657631.375,"total_display":"2,657,631.38","total_whole":"2,657,631","shares_owned_after":29875.0,"shares_owned_after_display":"29,875","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-01","filed_date":"2012-03-05","scope":"insider","n_lines":2},{"id":8846914,"accession":"0001127602-11-010253","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001127602-11-010253","line_url":"/filing/0001127602-11-010253","is_derivative":false,"issuer_cik":"0000946840","issuer_name":"VIROPHARMA INC","issuer_ticker":"VPHM","issuer_name_source":null,"issuer_url":"/issuer/0000946840","owner_cik":"0001383292","owner_name":"Rowland Charles A Jr","owner_display_name":"Rowland Charles A Jr","owner_url":"/insider/0001383292","role":"Officer (VP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (VP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35000.0,"shares_display":"35,000","price_per_share":18.57,"price_display":"18.57","price_state":"stated","total_value":649950.0,"total_display":"649,950.00","total_whole":"649,950","shares_owned_after":28496.0,"shares_owned_after_display":"28,496","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-03-14","filed_date":"2011-03-15","scope":"insider","n_lines":2},{"id":5660256,"accession":"0001181431-09-011976","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-09-011976","line_url":"/filing/0001181431-09-011976","is_derivative":false,"issuer_cik":"0000946840","issuer_name":"VIROPHARMA INC","issuer_ticker":"VPHM","issuer_name_source":null,"issuer_url":"/issuer/0000946840","owner_cik":"0001383292","owner_name":"Rowland Charles A Jr","owner_display_name":"Rowland Charles A Jr","owner_url":"/insider/0001383292","role":"Officer (VP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (VP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":16000.0,"shares_display":"16,000","price_per_share":4.782614375,"price_display":"4.78","price_state":"stated","total_value":76521.83,"total_display":"76,521.83","total_whole":"76,522","shares_owned_after":19817.0,"shares_owned_after_display":"19,817","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-02-26","filed_date":"2009-02-27","scope":"insider","n_lines":2},{"id":3453422,"accession":"0001181431-08-059861","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-08-059861","line_url":"/filing/0001181431-08-059861#line-1","is_derivative":false,"issuer_cik":"0000946840","issuer_name":"VIROPHARMA INC","issuer_ticker":"VPHM","issuer_name_source":null,"issuer_url":"/issuer/0000946840","owner_cik":"0001383292","owner_name":"Rowland Charles A Jr","owner_display_name":"Rowland Charles A Jr","owner_url":"/insider/0001383292","role":"Officer (VP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (VP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8000.0,"shares_display":"8,000","price_per_share":12.77,"price_display":"12.77","price_state":"stated","total_value":102160.0,"total_display":"102,160.00","total_whole":"102,160","shares_owned_after":8000.0,"shares_owned_after_display":"8,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-11-03","filed_date":"2008-11-05","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":30,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":14,"open_market":true},{"code":"S","label":"Open-market sale","n":16,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":30},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001607678","name":"Viking Therapeutics, Inc.","url":"/issuer/0001607678","role":"Director","n_filings":3,"first_seen":"2018-05-31","last_seen":"2025-10-28"},{"type":"issuer","type_label":"ISSUER","cik":"0001733294","name":"Generation Bio Co.","url":"/issuer/0001733294","role":"Director","n_filings":6,"first_seen":"2020-06-18","last_seen":"2023-12-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001641640","name":"Nabriva Therapeutics plc","url":"/issuer/0001641640","role":"Director","n_filings":3,"first_seen":"2018-12-27","last_seen":"2022-08-03"},{"type":"issuer","type_label":"ISSUER","cik":"0001597264","name":"Blueprint Medicines Corp","url":"/issuer/0001597264","role":"Director","n_filings":3,"first_seen":"2019-06-24","last_seen":"2020-12-18"},{"type":"issuer","type_label":"ISSUER","cik":"0000946840","name":"VIROPHARMA INC","url":"/issuer/0000946840","role":"Officer (VP, Chief Financial Officer)","n_filings":4,"first_seen":"2008-11-05","last_seen":"2012-03-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001383292","retrieved_at":"2026-08-26T10:16:17+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}